Drug Shortage Report for 0.9% SODIUM CHLORIDE INJECTION
Report ID | 112614 |
Drug Identification Number | 02395150 |
Brand name | SODIUM CHLORIDE 0.9% INJECTION |
Common or Proper name | Sodium Chloride 0,9% 250ml (FFX+) |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM CHLORIDE |
Strength(s) | 900MG |
Dosage form(s) | SOLUTION SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 250 ml |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2020-04-20 |
Actual start date | 2020-04-20 |
Estimated end date | 2020-06-05 |
Actual end date | 2020-05-26 |
Shortage status | Resolved |
Updated date | 2020-05-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2020-05-27 | English | Compare |
v7 | 2020-05-26 | French | Compare |
v6 | 2020-05-26 | English | Compare |
v5 | 2020-04-29 | French | Compare |
v4 | 2020-04-29 | English | Compare |
v3 | 2020-04-21 | English | Compare |
v2 | 2020-04-20 | French | Compare |
v1 | 2020-04-20 | English | Compare |
Showing 1 to 8 of 8